<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.896687</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The AhR ligand phthiocol and vitamin K analogs as <italic>Pseudomonas aeruginosa</italic> quorum sensing inhibitors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Jia</surname> <given-names>Tianyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1721580/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Dongjing</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bi</surname> <given-names>Xianbiao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Menglu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cai</surname> <given-names>Zhao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fu</surname> <given-names>Jiapeng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Zhi</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Pengyao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ke</surname> <given-names>Xue</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jia</surname> <given-names>Aiqun</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Guoliang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/585979/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Guobao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1738570/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Liang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1016671/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Medicine, Southern University of Science and Technology</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Shenzhen Third People&#x00027;s Hospital, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>School of Pharmaceutical Sciences, Hainan University</institution>, <addr-line>Haikou</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Shenzhen Key Laboratory of Gene Regulation and Systems Biology, Southern University of Science and Technology</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Laura Quintieri, Italian National Research Council, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Yue Qu, The Alfred Hospital, Australia; Zhijun Song, Sydvestjysk Sygehus, Denmark</p></fn>
<corresp id="c002">&#x0002A;Correspondence: Liang Yang <email>yangl&#x00040;sustech.edu.cn</email></corresp>
<corresp id="c001">Guobao Li <email>feisanke-01&#x00040;szsy.sustech.edu.cn</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn></author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>896687</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>08</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Jia, Liu, Bi, Li, Cai, Fu, Liu, Wu, Ke, Jia, Zhang, Li and Yang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Jia, Liu, Bi, Li, Cai, Fu, Liu, Wu, Ke, Jia, Zhang, Li and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<p>The aryl hydrocarbon receptor (AhR) protein senses microbial-secreted metabolites to trigger the host&#x00027;s innate immune system. The <italic>Pseudomonas</italic> quinolone signal (PQS) and <italic>Mycobacterium tuberculosis</italic> (MTb) metabolite phthiocol (Pht) are both ligands of AhR with similar chemical structures. As PQS is an essential quorum-sensing molecule that regulates a wide range of virulence factors in <italic>Pseudomonas aeruginosa</italic>, we hypothesized that Pht and its analogs are potential <italic>P. aeruginosa</italic> quorum-sensing inhibitors (QSIs) with immune-modulating functions. In this study, we demonstrated that Pht was able to inhibit the <italic>P. aeruginosa pqs</italic> QS system and reduce both biofilm formation and the production of pyocyanin. Molecular docking analysis suggested that Pht competes with PQS at the binding site of its receptor, PqsR. An electrophoretic mobility shift assay confirmed the Pht-PqsR interaction and showed that Pht attenuated PqsR from binding to the <italic>pqsA</italic> promoter. Proteomic analysis showed that synthesis of the key <italic>pqs</italic> QS proteins decreased upon the addition of Pht to the bacterial cultures. Furthermore, Pht analogs vitamins K<sub>1</sub> (Phylloquinone), K<sub>2</sub> (Menaquinones), and K<sub>3</sub> (Menadione) were also showed to inhibit the <italic>P. aeruginosa pqs</italic> QS system while able to activate the AhR signaling pathways. Our study suggests that the AhR ligands Pht and its vitamin K analogs are promising QSIs for the alternative treatment of <italic>P. aeruginosa</italic> infections.</p></abstract>
<kwd-group>
<kwd>aryl hydrocarbon receptor</kwd>
<kwd>phthiocol</kwd>
<kwd>vitamin K</kwd>
<kwd><italic>Pseudomonas aeruginosa</italic></kwd>
<kwd><italic>Pseudomonas</italic> quinolone signal</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="51"/>
<page-count count="15"/>
<word-count count="8281"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The aryl hydrocarbon receptor (AhR) protein is a highly conserved ligand-dependent transcription factor that senses xenobiotics to activate detoxifying monooxygenase cytochrome P4501 (CYP1) for degrading ligands to metabolites; it also plays a key role in immune control (Leclerc et al., <xref ref-type="bibr" rid="B30">2021</xref>). Besides its well-known ligands-environmental pollutants, AhR can also sense secreted microbial metabolites such as pigments and signaling molecules. Recent studies showed that AhR can recognize the <italic>Pseudomonas aeruginosa</italic> quorum-sensing molecule 2-heptyl-3-hydroxy-4 (1H)-quinolone (<italic>Pseudomonas</italic> quinolone signal, PQS) (Moura-Alves et al., <xref ref-type="bibr" rid="B35">2019</xref>) and <italic>M. tuberculosis</italic> (MTb) metabolite 2-hydroxy-3-methyl-1,4-naphthoquinone (phthiocol, Pht) (Moura-Alves et al., <xref ref-type="bibr" rid="B34">2014</xref>) as its ligands. After binding, AhR either activates or suppresses the expression of its regulated genes that are involved in a wide range of pathways, such as cell signaling, innate immune response, and the control of inflammation levels against bacterial infections. Since PQS and Pht are both ligands of AhR with similar chemical structures, we hypothesized that these two molecules may be competitive in binding the native PQS receptor in <italic>P. aeruginosa</italic>, PqsR. A very early study reported that Pht inhibits the growth of <italic>Streptococcus pyogenes, Escherichia coli</italic>, and other bacteria (Lichstein and Van De Sand, <xref ref-type="bibr" rid="B31">1946</xref>). Recently, Pht was shown to exhibit moderate anti-<italic>P.aeruginosa</italic> activity due to its metal ion chelating capacity (Shinde and Wadekar, <xref ref-type="bibr" rid="B44">2018</xref>), which is also a feature of the PQS molecule. However, it remains unclear whether Pht is indeed able to interfere with <italic>P. aeruginosa</italic> PQS signaling.</p>
<p><italic>Pseudomonas aeruginosa</italic> is a widespread opportunistic gram-negative bacterium responsible for many human infections (Curran et al., <xref ref-type="bibr" rid="B5">2018</xref>). The chronic infection caused by multi-drug resistant <italic>P. aeruginosa</italic> is the leading cause of death in patients with cystic fibrosis (Holmes et al., <xref ref-type="bibr" rid="B20">2021</xref>). <italic>Mycobacteria</italic> (such as MTb and <italic>Mycobacterium abscessus</italic>) and <italic>P. aeruginosa</italic> both cause diseases in human lungs and share the same ecological niche (Ehrt et al., <xref ref-type="bibr" rid="B8">2018</xref>). Recent studies suggest that these two pathogens are likely to cause co-infection and aggravate inflammatory lung disease (Falkinham et al., <xref ref-type="bibr" rid="B9">2015</xref>). Clinical studies on tuberculosis with recurrent <italic>P. aeruginosa</italic> infection in the lower respiratory tract showed that these patients have refractory sepsis and low immunity (Dos Santos et al., <xref ref-type="bibr" rid="B7">2012</xref>). Moreover, the incidence of <italic>P. aeruginosa</italic> infection in patients with tuberculosis is very high, significantly increasing the risk of in-hospital death among patients with pulmonary TB (Martiniano et al., <xref ref-type="bibr" rid="B33">2014</xref>). As MTb and <italic>P. aeruginosa</italic> share the same ecological niche in the human body, they may compete for limited nutrients in the lung (Devi et al., <xref ref-type="bibr" rid="B6">2021</xref>). Thus, we hypothesized that there may be some mechanism of agonism between these two species.</p>
<p>Several strategies to combat <italic>P. aeruginosa</italic> biofilm infections have been developed in recent years, including compounds that do not affect the growth of bacterial cells but can inhibit or disperse biofilms, which are believed to reduce the emergency of &#x0201C;new drug resistance&#x0201D; (Majik and Parvatkar, <xref ref-type="bibr" rid="B32">2014</xref>). The quorum sensing (QS) systems mediated by diffusible signaling molecules are among the most efficient regulatory mechanisms for <italic>P. aeruginosa</italic>, which regulate biofilm formation, secretion mechanisms, and the release of a large set of virulence factors such as pyocyanin (Lau et al., <xref ref-type="bibr" rid="B28">2004a</xref>), elastase (Galloway, <xref ref-type="bibr" rid="B12">1991</xref>), and rhamnolipids (Sober&#x000F3;n-Ch&#x000E1;vez et al., <xref ref-type="bibr" rid="B45">2005</xref>). A few classes of <italic>P. aeruginosa</italic> QS inhibitors (QSIs) have been shown to act as efficient biofilm inhibitors, including meta-bromo-thiolactone (mBTL) (O&#x00027;loughlin et al., <xref ref-type="bibr" rid="B37">2013</xref>), triazole-containing 2-phenylindole, salicylic acid (Srinivasarao et al., <xref ref-type="bibr" rid="B47">2018</xref>), and 6-gingerol (Kim et al., <xref ref-type="bibr" rid="B27">2015</xref>). However, most of the QSI compounds for <italic>P. aeruginosa</italic> were identified from synthetic compound libraries (Kalia, <xref ref-type="bibr" rid="B25">2013</xref>), which may have the problem of high toxicity to the human body (Kalia et al., <xref ref-type="bibr" rid="B26">2019</xref>). It makes sense to identify QSIs from microbial metabolites secreted by microorganisms colonizing the human body. <italic>Pseudomonas aeruginosa</italic> PQS can be found in the sputum of patients during infections (Pesci et al., <xref ref-type="bibr" rid="B40">1999</xref>). After binding to its specific receptor PqsR, PQS can activate the expression of the <italic>pqs</italic> QS regulated genes (Soheili et al., <xref ref-type="bibr" rid="B46">2019</xref>), including those responsible for the biosynthesis of pyocyanin and pyoverdine (Garc&#x000ED;a-Reyes et al., <xref ref-type="bibr" rid="B13">2020</xref>). Therefore, blocking the <italic>pqs</italic> QS system will impair the ability of <italic>P. aeruginosa</italic> to form biofilms and produce virulence factors, thus attenuating infections.</p>
<p>In this study, Pht was shown to reduce the <italic>pqsA-gfp</italic> bioreporter expression in a dose-dependent manner in <italic>P. aeruginosa</italic>. Moreover, we showed that Pht can decrease biofilm formation and pyocyanin production of <italic>P. aeruginosa</italic>. The molecular docking analysis suggested that PQS and Pht bind to the same cavity of PqsR. The EMSA assay showed that Pht can inhibit PqsR protein from binding to the <italic>pqsA</italic> promoter. The production of the key <italic>pqs</italic> QS proteins, including PqsB, PqsD, and PqsA, was decreased by adding Pht into the bacterial culture according to the proteomic analysis. We further revealed that Pht analogs and vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub>, could also inhibit the <italic>P. aeruginosa pqs</italic> QS system. Thus, our data suggested that the AhR ligand Pht and its vitamin K analogs are dual-functional molecules that can interfere with the <italic>P. aeruginosa pqs</italic> QS system and promote an AhR-dependent innate defense mechanism against bacteria.</p></sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Cell cultivation</title>
<p>THP-1 (human monocytes, ATCC TIB-202) and THP-1 AhR reporter (Moura-Alves et al., <xref ref-type="bibr" rid="B35">2019</xref>) cells were grown in RPMI 1,640 (GIBCO), supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS; GIBCO), and 1% (v/v) penicillin-streptomycin (GIBCO). All AhR reporter cell lines were maintained with an additional 5 mg/mL of Puromycin (Calbiochem). Cells were kept at 37&#x000B0;C in 5% CO<sub>2</sub>. Lentiviral infection was performed as described previously (Moura-Alves et al., <xref ref-type="bibr" rid="B35">2019</xref>) and according to the protocols available on the RNAi Consortium website (<ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/gpp/public/">https://portals.broadinstitute.org/gpp/public/</ext-link>). A similar protocol was used to generate the THP-1 Control and THP-1 AhR-Knockdown (KD) cell lines.</p></sec>
<sec>
<title>RNA isolation and real-time quantitative-PCR</title>
<p>To quantify the expression of genes of interest, the THP-1 cells were grown in 24-well plates for 24 h with or without PQS/Pht/vitamin K addition. Total RNA was extracted using the TRIzol LS reagent (Invitrogen, California, USA). The qRT-PCR assay was performed using the ABI 7500 sequence detection system (Applied Biosystems, California, USA). Three replicates were performed with the glyceraldehyde-3-phosphate dehydrogenase gene (<italic>GAPDH</italic>) as the internal control gene.</p></sec>
<sec>
<title>Molecular docking</title>
<p>The AhR and PqsR PDB structure files were downloaded from the Uniprot database and modified in PyMOL v. 1.4 (Schrodinger, LLC) (Seeliger and De Groot, <xref ref-type="bibr" rid="B43">2010</xref>). The PQS, Pht, and vitamin K molecule files were downloaded from the Pubchem database. The docking process between proteins and potential ligands was performed in the Autodock Vina plug-in inside Chimera (Pettersen et al., <xref ref-type="bibr" rid="B41">2004</xref>) (UCSF). The software program LIGPLOT v.4.5.3 (Wallace et al., <xref ref-type="bibr" rid="B48">1995</xref>) was used to map the interactions between proteins and potential ligands. Open babel software (O&#x00027;boyle et al., <xref ref-type="bibr" rid="B36">2011</xref>) was used to transfer proper file formats.</p></sec>
<sec>
<title>Microscale thermophoresis</title>
<p>The human recombinant AhR protein with Val128-Asn399 and N-terminal His-Tag was purchased from ImmunoClone (New York, USA). The binding of ligands to the AhR protein was assessed by microscale thermophoresis (MST) experiments using the Monolith<sup>&#x000AE;</sup> NT.LabelFree (NanoTemper Technologies GmbH). MST measurements were performed according to the manufacturer&#x00027;s instructions previously described (Moura-Alves et al., <xref ref-type="bibr" rid="B35">2019</xref>). The interaction affinity of the dissociation constant Kd for each ligand was analyzed using the NanoTemper Affinity software by the changes in the normalized fluorescence (fraction bound) vs. the ligand concentration.</p></sec>
<sec>
<title>Bacterial strains and media</title>
<p>Bacterial strains and plasmids used in this study are described in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>. Bacteria were cultured in Luria&#x02013;Bertani (LB) broth (1% tryptone, 0.5% yeast extract, 0.5% NaCl) and ABTGC (B-medium (0.1% MgCl<sub>2</sub>, 0.1% CaCl<sub>2</sub>, 0.1% FeCl<sub>3</sub>) supplemented with 10% A10, 0.2% glucose, and 0.2% casamino acids). The media were solidified with 1.5% Bacto Agar (Difco). Kings&#x00027; medium [Milli-Q water supplemented with proteose peptone (20 g/L), potassium sulfate (10 g/L), magnesium chloride, anhydrous (1.640 g/L), and glycerol (10% v/v)] were used for the pyocyanin quantification assay.</p></sec>
<sec>
<title><italic>P. aeruginosa</italic> mutant construction</title>
<p><italic>Pseudomonas aeruginosa</italic> mutant strains &#x00394;<italic>pqsC</italic> and &#x00394;<italic>pqsR</italic> were generated by homologous recombination using the previously described protocol (Choi and Schweizer, <xref ref-type="bibr" rid="B2">2005</xref>). The mutants were constructed by overlapping PCR to contain a gentamicin-resistance cassette. The mutant fragments were inserted into pK18, a suicide vector, to produce gene knockout plasmids. Each knockout plasmid was transformed into <italic>E. coli</italic> strain RK600 and conjugally transferred from RK600 to PAO1. The resultant integrants were selected on agar containing 30 &#x003BC;g/mL gentamicin (Gm30). To resolve merodiploids, we streaked the Gm-resistant colonies for single colonies on LB&#x0002B;Gm30 plates containing 5% sucrose. Potential mutants were screened by PCR using corresponding flanking primers and were confirmed by Sanger sequencing.</p></sec>
<sec>
<title><italic>P. aeruginosa</italic> QS inhibition and growth curve assays</title>
<p>PQS and Pht compounds were prepared in a 96-well microtiter plate (Nunc, Denmark) at a concentration of 100 mM in DMSO. PQS and Pht were then mixed with ABTGC medium and serial dilutions to give a concentration of 125, 250, 500, 750, 1,000, 1,500, and 2,000 nM, respectively. An overnight culture of the PAO1-<italic>pqsA</italic>-<italic>gfp</italic> strain (grown in LB medium at 37&#x000B0;C, 200 rpm) was diluted in ABTGC medium to a final optical density at 600 nm (OD<sub>600nm</sub>) of 0.02 (&#x0007E;2.5 &#x000D7; 10<sup>8</sup> CFU/mL). A DMSO control (0.1% final concentration) and blank control (ABTGC medium) were used. The microtiter plate was incubated at 37&#x000B0;C in a Tecan Infinite 200 Pro plate reader (Tecan Group Ltd., Mannedorf, Switzerland) to measure the cell density (OD<sub>600nm</sub>) and GFP fluorescence (excitation at 485 nm, emission at 535 nm) at 30 min intervals for at least 12 h. The inhibition assay for PQS and Pht was done in triplicate. Growth curve assays were performed only by measuring the cell density (OD<sub>600nm</sub>) using the same method above.</p></sec>
<sec>
<title>Pyocyanin quantification assay</title>
<p>Overnight cultures of <italic>P. aeruginosa</italic> WT and &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic> mutant strains were standardized to an OD<sub>600nm</sub> of 0.1 and diluted 100 times into 25 mL of fresh King&#x00027;s Medium in a 250 mL flask. The PQS and Pht compounds were added to give a final concentration of 750 nM. The cultures were grown for 48 h at 37&#x000B0;C in shaking conditions (200 rpm). The cultures were monitored every 24 h to observe any color change from light-yellow to greenish-yellow in the untreated flask. The mutant strain &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic> was used as the negative control. The final cell density was measured at 600 nm (OD<sub>600nm</sub>) using a Tecan Infinate 200 Pro plate reader (Tecan Group Ltd., Mannedorf, Switzerland). The cultures were then centrifuged for 10 min at 10,000 rpm, and 7.5 mL of the supernatants were transferred into new Falcon tubes. Pyocyanin extraction was conducted using chloroform (3 mL) and 0.2 M HCl (1.5 mL). The top aqueous layer of HCl containing pyocyanin was pipetted into a microtiter plate, and absorbance was measured at 520 nm. The data was normalized by dividing the OD<sub>520nm</sub> reading by the final OD<sub>600nm</sub> values.</p></sec>
<sec>
<title>Biofilm formation assay</title>
<p>Biofilm formation was quantified by crystal violet staining. Overnight LB-grown cultures were diluted in fresh medium (1:100) and incubated in 2 mL of LB in 15 mL tubes at 37&#x000B0;C for 24 h, statically allowing biofilm formation. After removing the spent media, we removed the loosely associated bacteria by washing them with water two times, and the remaining bacteria were stained with 0.1% crystal violet for 20 min. Then, the crystal violet stain was discarded while the stained biofilms were washed twice thoroughly with ddH<sub>2</sub>O and air-dried. The stained biofilm was then dissolved into 200 &#x003BC;L of 95% ethanol and quantified at 630 nm using a Tecan Infinate 200 Pro plate reader (Tecan Group Ltd., Mannedorf, Switzerland).</p></sec>
<sec>
<title>The electrophoretic mobility shift assay</title>
<p>EMSA assays were performed using cell lysates of PAO1 and <italic>pqsR</italic> mutants as previously described (Gruber et al., <xref ref-type="bibr" rid="B15">2016</xref>). For each sample, cell-lysate was incubated with biotinylated 248-bp <italic>pqsA</italic> promoter DNA (pqsA&#x02032;), which was generated by PCR using biotinylated forward primer (TTCTTGCTTGGTTGCCG) and reverse primer (GACAGAACGTTCCCTCTT). The reaction mixture contained 10 mM Tris&#x02013;HCl (pH 8.0), 1 mM EDTA, 50 mM NaCl, 1 mM DTT, 1 &#x003BC;g/&#x003BC;L Poly (dI-dC) and was incubated at room temperature (24&#x000B0;C) for 20 min. Samples were separated on a 5% polyacrylamide gel in 0.5 &#x000D7; Tris Borate EDTA (TBE) run at 100 V for 120 min and transferred onto a positively-charged nylon membrane at 40 V for 1 h. Biotinylated DNA on the nylon membrane was probed by streptavidin-HRP conjugate, detected by a chemiluminescent substrate (Beyotime EMSA kit; Shanghai, China), and visualized by exposing it to a GE ImageQuant RT-ECL instrument.</p></sec>
<sec>
<title>Tandem mass tag-based quantitative proteomic analysis</title>
<p>Overnight PAO1 cultures were diluted 100 times into 25 mL of fresh LB medium. A Pht compound was added to one sample to give a final concentration of 750 nM. Then, total proteins were extracted from bacterial samples and trypsin digested. Then, the digested sample was labeled with a TMT reagent. Next, TMT labeled peptide was separated by a RIGOL L-3000 dual gradient High-Performance Liquid Chromatography (HPLC) using an Agela Durashell-C18 column. An HPLC-separated peptide was identified by nano UPLC-MS/MS consisting of a Nanoflow HPLC system (EASY-nLC 1000 system from Thermo Scientific) with an EASY-Spray C18 column and an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific). Then, the protein was identified using the Uniprot_HUMAN database. The resulting MS/MS data were processed using Proteome Discoverer 2.4. The final results were functionally annotated by Gene Ontology (GO) (Zhang et al., <xref ref-type="bibr" rid="B51">2019</xref>), KEGG (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg/">https://www.genome.jp/kegg/</ext-link>) (Jones et al., <xref ref-type="bibr" rid="B24">2014</xref>), and STRING (<ext-link ext-link-type="uri" xlink:href="https://www.string-db.org">https://www.string-db.org</ext-link>) (Franceschini et al., <xref ref-type="bibr" rid="B10">2013</xref>).</p></sec>
<sec>
<title>Statistical analyses</title>
<p>All statistical analyses were performed using GraphPad Prism software with a two-sided Mann-Whitney <italic>U</italic>-test and Benjamini-Hochberg-corrected <italic>P-</italic>values. Data represent the mean &#x000B1; standard deviation (SD) of three independent experiments unless otherwise indicated. <italic>P-</italic>values &#x0003C; 0.05 were considered statistically significant. All false discovery rate controls were performed with the Benjamini-Hochberg procedure, and a false-discovery rate of 10% (<italic>q</italic> &#x0003C; 0.1) was selected as the significant threshold. Statistical details for all tests performed can be found in the figure legends.</p></sec></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>PQS inhibited while Pht activated AhR downstream genes <italic>CYP1B1</italic> and <italic>AHRR</italic> in THP-1 human monocytes</title>
<p><italic>Pseudomonas aeruginosa</italic> QS signal molecule PQS has been reported to downregulate AhR-induced cytochrome P4501 (CYP1) enzyme and CYP1A1 enzymatic activities in mouse liver cells (Hepa-1c1c7) (Moura-Alves et al., <xref ref-type="bibr" rid="B35">2019</xref>). We demonstrated by qRT-PCR that the transcription of two AhR downstream genes, <italic>CYP1B1</italic> and AhR repressor (<italic>AHRR</italic>), was repressed 2.3- and 2.5-fold with the addition of 10 &#x003BC;M PQS in THP-1 human monocytes compared to control (additional of DMSO alone) (<xref ref-type="fig" rid="F1">Figures 1A</xref>,<xref ref-type="fig" rid="F1">B</xref>). In addition, there were no significant expression changes of these genes in the THP-1 KD cells upon PQS addition.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>PQS inhibited while Pht activated AhR downstream genes in THP-1 human monocytes. <bold>(A,B)</bold> qRT-PCR quantification of the expression of <italic>CYP1B1</italic> and <italic>AHRR</italic> in THP-1 Control and AhR KD cells with PQS addition. <bold>(C,D)</bold> qRT-PCR quantification of the expression of <italic>CYP1B1</italic> and <italic>AHRR</italic> in THP-1 Control and AhR KD cells with Pht addition. Data are presented as means &#x000B1; SD; <italic>n</italic> = three independent experiments (&#x0002A;<italic>P</italic> &#x02264; 0.05 and &#x0002A;&#x0002A;<italic>P</italic> &#x02264; 0.01, Mann-Whitney <italic>U</italic>-test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0001.tif"/>
</fig>
<p>The MTb natural metabolite Pht was found to activate <italic>CYP1B1</italic> and <italic>AHRR</italic> transcription in THP-1 cells in an AhR-dependent manner (Moura-Alves et al., <xref ref-type="bibr" rid="B34">2014</xref>). Our qRT-PCR results also confirmed that <italic>CYP1B1</italic> and <italic>AHRR</italic> transcription were promoted by 2.2- and 1.9-fold with the addition of 10 &#x003BC;M Pht in THP-1 human monocytes compared to control (DMSO only), respectively (<xref ref-type="fig" rid="F1">Figures 1C</xref>,<xref ref-type="fig" rid="F1">D</xref>). These results demonstrated that PQS and Pht adversely affected AhR regulatory pathways.</p></sec>
<sec>
<title><italic>In vitro</italic> assays of PQS or Pht interactions with AhR</title>
<p>The chemical structures of the <italic>P. aeruginosa</italic> auto-inducer PQS and MTb Pht are shown in <xref ref-type="fig" rid="F2">Figures 2A</xref>,<xref ref-type="fig" rid="F2">D</xref>. Molecular docking was performed using the ligands PQS and Pht against the ligand-binding domain of the human AhR protein. These compounds and their structures are shown in <xref ref-type="fig" rid="F2">Figures 2B</xref>,<xref ref-type="fig" rid="F2">E</xref>. To map the interactions between PQS and the residues within the ligand-binding site on AhR, we used the software LIGPLOT v. 4.5.3 (Wallace et al., <xref ref-type="bibr" rid="B48">1995</xref>). This program provides a 2-dimensional map showing the hydrogen-bond and hydrophobic interactions between atoms in the ligand and those of the binding partner.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>PQS and Pht were able to bind to AhR protein. <bold>(A,D)</bold> Molecular structures of <italic>P. aeruginosa</italic> PQS and MTb Pht. <bold>(B,E)</bold> The interaction model of the AhR protein with PQS or Pht. <bold>(C,F)</bold> Interaction map between residues within the AhR protein with PQS or Pht. <bold>(G)</bold> Quantifying the binding affinity of AhR protein with PQS or Pht using microscale thermophoresis assay.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0002.tif"/>
</fig>
<p>The results showed that PQS binds to the AhR protein through hydrophobic forces, and they appear to interact at residues Gln 277, Tyr 221, Pro 200, Ile 281, Ser 220, Phe 228, Phe 201, Ala 224, Lys 225, and Tyr 264 (<xref ref-type="fig" rid="F2">Figure 2C</xref>). However, the docking analysis suggested that Pht and AhR appeared to interact at residues Tyr 84, Ala 46, Ile 101, Pro 22, Phe 23, Tyr 43, Ser 42, and Leu 39 (<xref ref-type="fig" rid="F2">Figure 2F</xref>).</p>
<p>Next, we used an MST assay to quantify the AhR binding affinity with different ligands, including PQS and Pht. The MST results indicated that the dissociation constant (Kd) values of AhR protein with PQS and Pht were 3.75 &#x003BC;M and 474.41 nM, respectively (<xref ref-type="fig" rid="F2">Figure 2G</xref>). These results confirmed that PQS and Pht directly bind to AhR protein as ligands.</p></sec>
<sec>
<title>Effects of Pht on <italic>P. aeruginosa pqs</italic> QS system, pyocyanin production, and biofilm formation</title>
<p>To engineer a PQS auto-inducer reporter system, we first made a PQS deficient &#x00394;<italic>pqsC</italic> mutant by deleting the <italic>pqsC</italic> gene. The <italic>pqsA</italic>-<italic>gfp</italic> reporter plasmid (Yang et al., <xref ref-type="bibr" rid="B50">2007</xref>) was next transferred into the &#x00394;<italic>pqsC</italic> mutant to make the PQS biosensor strain &#x00394;<italic>pqsC</italic> P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. In addition, the <italic>pqsA</italic>-<italic>gfp</italic> reporter plasmid was transferred into the PAO1 WT to make the PQS bioreporter strain PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. Induction of the <italic>pqsA</italic> gene is mainly controlled by PqsR (the signal receptor of the <italic>pqs</italic> QS system), which is activated by the presence of PQS (Soheili et al., <xref ref-type="bibr" rid="B46">2019</xref>). Thus, in the PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub> strain, a decrease in GFP fluorescence would indicate the presence of an antagonist of PQS, while exogenous PQS was needed to induce the GFP fluorescence of the &#x00394;<italic>pqsC</italic> P<sub>pqsA&#x02212;<italic>gfp</italic></sub> strain.</p>
<p>Pht was exogenously added to both the above reporter strains to evaluate its impact on the <italic>pqs</italic> QS system. As shown in <xref ref-type="fig" rid="F3">Figure 3A</xref>, both PQS and Pht could not affect the growth of the <italic>P. aeruginosa</italic> strain. PQS&#x02014;not Pht&#x02014;induced the <italic>pqsA</italic>-<italic>gfp</italic> expression in a dose-dependent manner in the PAO1 &#x00394;<italic>pqsC</italic> strain (<xref ref-type="fig" rid="F3">Figure 3B</xref>). In contrast, Pht was able to inhibit <italic>pqsA</italic>-<italic>gfp</italic> expression in a dose-dependent manner in the PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub> strain, with the optimal effect at a concentration of 750 nM (<xref ref-type="fig" rid="F3">Figure 3C</xref>). These results showed that PQS activated while Pht inhibited the <italic>P. aeruginosa pqs</italic> QS system.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Pht inhibited <italic>P. aeruginosa pqs</italic> QS system, pyocyanin production, and biofilm formation. <bold>(A)</bold> Growth curves of <italic>P. aeruginosa</italic> PAO1 WT and QS mutant strain under different conditions. <bold>(B)</bold> Dose-dependent induction curves of PQS in &#x00394;<italic>pqsC</italic> P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. <bold>(C)</bold> Dose-dependent inhibition curves of Pht in PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. <bold>(D)</bold> The production of pyocyanin by <italic>P. aeruginosa</italic> WT, WT&#x0002B;750 nM Pht, &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic>, &#x00394;<italic>pqsC</italic>, &#x00394;<italic>pqsC</italic>&#x0002B;750 nM PQS strains. <bold>(E)</bold> Photos of visualization of the green pigment corresponding to the upper panel. <bold>(F)</bold> The biofilm formation of <italic>P. aeruginosa</italic> WT, WT&#x0002B;750 nM Pht, &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic>, &#x00394;<italic>pqsC</italic>, &#x00394;<italic>pqsC</italic>&#x0002B;750 nM PQS strains. Data are presented as means &#x000B1; SD; <italic>n</italic> = three independent experiments (&#x0002A;<italic>P</italic> &#x02264; 0.05 and &#x0002A;&#x0002A;<italic>P</italic> &#x02264; 0.01, Mann-Whitney <italic>U</italic>-test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0003.tif"/>
</fig>
<p>The production of pyocyanin and the formation of biofilms are <italic>pqs</italic> QS system-regulated phenotypes related to virulence in <italic>P. aeruginosa</italic> (Pearson et al., <xref ref-type="bibr" rid="B39">1997</xref>). Pyocyanin is a key virulence factor produced by <italic>P. aeruginosa</italic> that plays a major role in cystic fibrosis (CF) lung infections (Lau et al., <xref ref-type="bibr" rid="B28">2004a</xref>). Pyocyanin was shown to cause tissue damage and necrosis in a <italic>P. aeruginosa</italic> murine model for a lung infection (Lau et al., <xref ref-type="bibr" rid="B29">2004b</xref>). Biofilm formation by <italic>P. aeruginosa</italic> is well known as the cause of chronic infections (Costerton et al., <xref ref-type="bibr" rid="B4">2005</xref>). We thus evaluated the effects of Pht on these two phenotypes.</p>
<p>As expected, the pyocyanin production by <italic>P. aeruginosa</italic> PAO1 strain was found to be suppressed by Pht to a level comparable to that of PAO1 &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic> strain and the &#x00394;<italic>pqsC</italic> strain. It could be seen from the intensity of the green pigment in the supernatants of different samples that the PAO1 WT culture exhibited a dark green, &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic> and &#x00394;<italic>pqsC</italic> cultures exhibited light green, and the WT&#x0002B;Pht culture did not have a visible green color. These results indicated that Pht inhibited pyocyanin production (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Crystal violet staining showed that the biofilm formation of <italic>P. aeruginosa</italic> PAO1 WT was suppressed by Pht to a level comparable to that of the PAO1 &#x00394;<italic>lasI</italic>&#x00394;<italic>rhlI</italic> and the &#x00394;<italic>pqsC</italic> strains (<xref ref-type="fig" rid="F3">Figures 3E</xref>,<xref ref-type="fig" rid="F3">F</xref>). Besides, we detected that Pht did not inhibit <italic>P. aeruginosa</italic> rhamnolipid productions (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>). These results indicated that Pht repressed <italic>P. aeruginosa pqs</italic> QS system, pyocyanin production, and biofilm formation.</p></sec>
<sec>
<title>Investigation of the interaction of Pht with PqsR protein</title>
<p>The interactions between alkyl quinolones with PqsR are simulated by the crystal structure of PqsR complexed with its ligand, which suggests the influence of ligand binding on PqsR affinity to its DNA-binding site (Ilangovan et al., <xref ref-type="bibr" rid="B21">2013</xref>). Molecular docking was first performed using the reference ligand PQS and potential ligand Pht against the ligand-binding domain of the <italic>P. aeruginosa</italic> PqsR protein. These compounds and their structures were shown (<xref ref-type="fig" rid="F4">Figures 4A</xref>,<xref ref-type="fig" rid="F4">C</xref>). To map the interactions between PQS and the residues within the ligand-binding site on PqsR, the software program LIGPLOT v. 4.5.3 was used.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Interaction of Pht with PqsR protein. Molecular docking of the PqsR protein with PQS or Pht. <bold>(A,C)</bold> The interaction model of the PqsR protein with PQS or Pht. <bold>(B,D)</bold> Interaction map between residues within the PqsR protein with PQS or Pht. <bold>(E)</bold> EMSA assays with biotinylated-<italic>pqsA</italic> promoters incubated with cell-lysates of PAO1 and &#x00394;<italic>pqsR</italic> strains. <bold>(F)</bold> The abundance of shifted cell-lysates corresponding to the upper panel was determined by measuring the densitometry in Image J.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0004.tif"/>
</fig>
<p>The results showed that PQS binds to PqsR protein by hydrophobic forces, and they appeared to interact at residues Leu 189, Tyr 258, Val 170, Ile 236, Ile 149, Ala 168, Thr 265, and Leu 207 (<xref ref-type="fig" rid="F4">Figure 4B</xref>). While the docking analysis suggested that Pht and PqsR appeared to interact at residues Ile 56, Leu 114, r103 (A), n101 (A), Met 131, Ile 143, Phe 128, and Leu 104 (<xref ref-type="fig" rid="F4">Figure 4D</xref>). Except for hydrophobic forces, Pht and PqsR are also predicted to be bound by a hydrogen bond at Leu 115 (A). These molecular docking results revealed that the QS signaling molecule PQS and Pht competed for the same active pocket in the PqsR protein. The hydrogen bond between Pht and PqsR might offer Pht an advantage when competing with PQS. Thus, we suspected that Pht competitively disrupted the PQS-mediated PqsR activation and signaling in <italic>P. aeruginosa</italic>. These predicted binding modes of PqsR and Pht need further experimental verification.</p>
<p>The electrophoretic mobility shift assay (EMSA) is a rapid and sensitive experimental method to detect protein-nucleic acid interactions (Hellman and Fried, <xref ref-type="bibr" rid="B17">2007</xref>). The protein-nucleic acid complexes migrate more slowly than the corresponding free nucleic acid in the gel. To test whether Pht will interact with PqsR and further affect its DNA binding capacity, we performed EMSA with the biotinylated-<italic>pqsA</italic> promoter (Bio-<italic>pqsA</italic>) using cell lysates of PAO1 WT and &#x00394;<italic>pqsR</italic> strains. The results showed that only PAO1 cell lysates shifted Bio-<italic>pqsA</italic> migration, while &#x00394;<italic>pqsR</italic> cell lysates did not show any effect. The addition of Pht attenuated the interaction between PAO1 cell lysates and Bio-<italic>pqsA</italic>, whereas there was no effect by adding the cell lysates of &#x00394;<italic>pqsR</italic> (<xref ref-type="fig" rid="F4">Figures 4E</xref>,<xref ref-type="fig" rid="F4">F</xref>). These results indicated that Pht could indeed block the binding of PqsR protein to the <italic>pqsA</italic> promoter, which further leads to the inhibitory effect against <italic>P. aeruginosa pqs</italic> QS systems.</p></sec>
<sec>
<title>Pht down-regulated the expression of <italic>pqs</italic> QS regulated proteome</title>
<p>To study the changes in the proteomic profile of <italic>P. aeruginosa</italic> PAO1 upon Pht addition, TMT was used as the labeling strategy for comparative quantitative proteomic analysis (performed with a false discovery rate below 1%). The following cutoffs were used for protein identification: an unused protein score of at least 2 (i.e., 99% confidence of identification) and having more than 1 peptide identified. Using these cutoffs, we identified 2,203 proteins. Using a <italic>p</italic>-value cutoff of 0.05, 37 proteins were found to be significantly affected by Pht. The expression of 10 proteins was upregulated, whereas the expression of 27 proteins was downregulated (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>).</p>
<p><xref ref-type="table" rid="T1">Table 1</xref> shows the 27 proteins whose abundances were significantly decreased in the Pht-treated <italic>P. aeruginosa</italic> PAO1 strain compared to those in the control PAO1 strain without Pht addition. Of these 27 proteins, five have been previously found to be <italic>pqs</italic> QS regulated: <italic>phnA</italic> (Anthranilate synthase component 1), <italic>pqsB</italic> (Anthraniloyl-CoA anthraniloyltransferase), <italic>phzD2</italic> (Phenazine biosynthesis protein PhzD2), <italic>pqsD</italic> (Anthraniloyl-CoA anthraniloyltransferase), and <italic>pqsA</italic> (Anthranilate&#x02013;CoA ligase). These results further confirmed that Pht directly attenuates <italic>P. aeruginosa pqs</italic> QS regulated global proteome network.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Protein expression changed in PAO1 WT with the addition of Pht<sup>a</sup>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Gene name</bold></th>
<th valign="top" align="left"><bold>Protein description</bold></th>
<th valign="top" align="center"><bold>Protein expression fold change</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Down-regulated:</bold></td>
</tr>
<tr>
<td valign="top" align="left"><italic>pqsA</italic></td>
<td valign="top" align="left">Anthranilate&#x02013;CoA ligase</td>
<td valign="top" align="center">0.84</td>
</tr>
<tr>
<td valign="top" align="left">PA2379</td>
<td valign="top" align="left">Probable oxidoreductase</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left">PA4046</td>
<td valign="top" align="left">Uncharacterized protein</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left"><italic>tatA</italic></td>
<td valign="top" align="left">Sec-independent protein translocase protein TatA</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left"><italic>uvrC</italic></td>
<td valign="top" align="left">UvrABC system protein C</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left">PA5220</td>
<td valign="top" align="left">Uncharacterized protein</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left"><italic>pqsD</italic></td>
<td valign="top" align="left">Anthraniloyl-CoA anthraniloyltransferase</td>
<td valign="top" align="center">0.83</td>
</tr>
<tr>
<td valign="top" align="left">PA1668</td>
<td valign="top" align="left">DotU domain-containing protein</td>
<td valign="top" align="center">0.82</td>
</tr>
<tr>
<td valign="top" align="left">PA0752</td>
<td valign="top" align="left">Uncharacterized protein</td>
<td valign="top" align="center">0.82</td>
</tr>
<tr>
<td valign="top" align="left"><italic>sdhC</italic></td>
<td valign="top" align="left">Succinate dehydrogenase cytochrome b556 subunit</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left">PA3331</td>
<td valign="top" align="left">Cytochrome P450</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left"><italic>nusG</italic></td>
<td valign="top" align="left">Transcription termination/antitermination protein NusG</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left">PA4357</td>
<td valign="top" align="left">FeoC domain-containing protein</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left"><italic>hcnC</italic></td>
<td valign="top" align="left">Hydrogen cyanide synthase subunit HcnC</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left"><italic>pilP</italic></td>
<td valign="top" align="left">Type IV pilus inner membrane component PilP</td>
<td valign="top" align="center">0.81</td>
</tr>
<tr>
<td valign="top" align="left"><italic>citA</italic></td>
<td valign="top" align="left">Citrate transporter</td>
<td valign="top" align="center">0.80</td>
</tr>
<tr>
<td valign="top" align="left"><italic>pmrB</italic></td>
<td valign="top" align="left">Sensor protein kinase PmrB</td>
<td valign="top" align="center">0.80</td>
</tr>
<tr>
<td valign="top" align="left">PA4591</td>
<td valign="top" align="left">HlyD_D23 domain-containing protein</td>
<td valign="top" align="center">0.80</td>
</tr>
<tr>
<td valign="top" align="left">PA2526</td>
<td valign="top" align="left">Probable Resistance-Nodulation-Cell Division (RND) efflux transporter</td>
<td valign="top" align="center">0.79</td>
</tr>
<tr>
<td valign="top" align="left">PA1655</td>
<td valign="top" align="left">Probable glutathione S-transferase</td>
<td valign="top" align="center">0.79</td>
</tr>
<tr>
<td valign="top" align="left">PA2252</td>
<td valign="top" align="left">Probable AGCS sodium/alanine/glycine symporter</td>
<td valign="top" align="center">0.78</td>
</tr>
<tr>
<td valign="top" align="left"><italic>pilO</italic></td>
<td valign="top" align="left">Type IV pilus inner membrane component PilO</td>
<td valign="top" align="center">0.77</td>
</tr>
<tr>
<td valign="top" align="left"><italic>phnA</italic></td>
<td valign="top" align="left">Anthranilate synthase component 1, pyocyanin specific</td>
<td valign="top" align="center">0.76</td>
</tr>
<tr>
<td valign="top" align="left">PA1654</td>
<td valign="top" align="left">Probable aminotransferase</td>
<td valign="top" align="center">0.76</td>
</tr>
<tr>
<td valign="top" align="left"><italic>wspC</italic></td>
<td valign="top" align="left">Probable biofilm formation methyltransferase WspC</td>
<td valign="top" align="center">0.76</td>
</tr>
<tr>
<td valign="top" align="left"><italic>roxS</italic></td>
<td valign="top" align="left">Histidine kinase</td>
<td valign="top" align="center">0.75</td>
</tr>
<tr>
<td valign="top" align="left">PA3677</td>
<td valign="top" align="left">Probable Resistance-Nodulation-Cell Division (RND) efflux membrane fusion protein</td>
<td valign="top" align="center">0.72</td>
</tr>
<tr>
<td valign="top" align="left"><italic>phzD2</italic></td>
<td valign="top" align="left">Phenazine biosynthesis protein PhzD2</td>
<td valign="top" align="center">0.68</td>
</tr>
<tr>
<td valign="top" align="left"><italic>purE</italic></td>
<td valign="top" align="left">N5-carboxyaminoimidazole ribonucleotide mutase</td>
<td valign="top" align="center">0.64</td>
</tr>
<tr>
<td valign="top" align="left"><italic>pqsB</italic></td>
<td valign="top" align="left">2-heptyl-4(1H)-quinolone synthase subunit PqsB</td>
<td valign="top" align="center">0.59</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Up-regulated:</bold></td>
</tr>
<tr>
<td valign="top" align="left">PA1224</td>
<td valign="top" align="left">Probable NAD(P)H dehydrogenase</td>
<td valign="top" align="center">1.56</td>
</tr>
<tr>
<td valign="top" align="left"><italic>fabZ</italic></td>
<td valign="top" align="left">3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ</td>
<td valign="top" align="center">1.39</td>
</tr>
<tr>
<td valign="top" align="left"><italic>ribH</italic></td>
<td valign="top" align="left">6,7-dimethyl-8-ribityllumazine synthase</td>
<td valign="top" align="center">1.33</td>
</tr>
<tr>
<td valign="top" align="left">PA5076</td>
<td valign="top" align="left">Probable binding protein component of ABC transporter</td>
<td valign="top" align="center">1.32</td>
</tr>
<tr>
<td valign="top" align="left">PA4880</td>
<td valign="top" align="left">Probable bacterioferritin</td>
<td valign="top" align="center">1.29</td>
</tr>
<tr>
<td valign="top" align="left">PA4739</td>
<td valign="top" align="left">BON domain-containing protein</td>
<td valign="top" align="center">1.25</td>
</tr>
<tr>
<td valign="top" align="left"><italic>nalC</italic></td>
<td valign="top" align="left">NalC</td>
<td valign="top" align="center">1.23</td>
</tr>
<tr>
<td valign="top" align="left"><italic>speD</italic></td>
<td valign="top" align="left">S-adenosylmethionine decarboxylase proenzyme</td>
<td valign="top" align="center">1.22</td>
</tr>
<tr>
<td valign="top" align="left"><italic>ihfB</italic></td>
<td valign="top" align="left">Integration host factor subunit beta</td>
<td valign="top" align="center">1.22</td>
</tr>
<tr>
<td valign="top" align="left">PA3779</td>
<td valign="top" align="left">Uncharacterized protein</td>
<td valign="top" align="center">1.22</td>
</tr>
</tbody>
</table><table-wrap-foot><p><sup>a</sup>Three replicates per sample in the log phase were performed for proteomics analysis.</p>
</table-wrap-foot>
</table-wrap></sec>
<sec>
<title>Vitamins K<sub>1</sub> upregulated AhR downstream genes <italic>CYP1B1</italic> and <italic>AHRR</italic> through AhR in THP-1 human monocytes</title>
<p>By comparing the online PubChem compound library (<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</ext-link>), we found several structural analogs of the Pht molecule, including vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> (<xref ref-type="fig" rid="F5">Figures 5A</xref>&#x02013;<xref ref-type="fig" rid="F5">C</xref>). Vitamin K is a fat-soluble vitamin that participates in blood clotting (Palermo et al., <xref ref-type="bibr" rid="B38">2017</xref>). Vitamin K deficiency may lead to prolonged blood clotting time, bleeding, and even death in severe cases (Palermo et al., <xref ref-type="bibr" rid="B38">2017</xref>). Vitamin K not only has protective effects on the heart and the cerebrovascular system but also has a maintenance effect on the normal elasticity of blood vessel walls and participates in the metabolism of bone for the prevention and cure of osteoporosis and fracture (Fusaro et al., <xref ref-type="bibr" rid="B11">2020</xref>). However, no evidence has yet shown that vitamin K can directly affect bacterial pathogenesis.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Pht analog vitamins K<sub>1</sub> increased the expression of AhR downstream genes in THP-1 human monocytes through AhR. <bold>(A&#x02013;C)</bold> The chemical construction of molecules of vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub>. <bold>(D,E)</bold> qRT-PCR of the expression of <italic>CYP1B1</italic> and <italic>AHRR</italic> in THP-1 control and AhR KD cells with vitamin K<sub>1</sub> addition. Data are presented as means &#x000B1; SD; <italic>n</italic> = three independent experiments (&#x0002A;<italic>P</italic> &#x02264; 0.05, Mann-Whitney <italic>U</italic>-test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0005.tif"/>
</fig>
<p>To reveal whether Pht analogs vitamin K families influence the AhR pathway, we performed qRT-PCR experiments to measure the transcription of AhR downstream genes. The results showed that <italic>CYP1B1</italic> and <italic>AHRR</italic> transcription was increased by 1.9- and 1.6-fold with the addition of 10 &#x003BC;M vitamin K<sub>1</sub> in THP-1 human monocytes compared to that with DMSO (<xref ref-type="fig" rid="F5">Figures 5D</xref>,<xref ref-type="fig" rid="F5">E</xref>). Besides, there is no change in AhR KD cells with vitamin K<sub>1</sub> stimulation. These results indicated that vitamin K<sub>1</sub> promoted AhR downstream genes <italic>CYP1B1</italic> and <italic>AHRR</italic> through AhR in THP-1 human monocytes.</p></sec>
<sec>
<title><italic>In vitro</italic> assays examining the interactions of vitamin K with AhR protein</title>
<p>Molecular docking was performed using the ligands vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> against the ligand-binding domain of the human AhR protein. <xref ref-type="fig" rid="F6">Figures 6A</xref>,<xref ref-type="fig" rid="F6">C</xref>,<xref ref-type="fig" rid="F6">E</xref> show these compounds and their structures. The LIGPLOT results showed that vitamin K<sub>1</sub> and AhR protein were bound by hydrophobic forces that appeared to interact at residues Tyr 221, Lys 225, Gln 277, Phe 201, Ala 224, Pro 200, Tyr 264, Phe 228, Val 253, Val 255, and Ile 281 (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Similarly, the docking analysis suggested that vitamins K<sub>2</sub> and K<sub>3</sub> with AhR appeared to interact at several vital residues (<xref ref-type="fig" rid="F6">Figures 6D</xref>,<xref ref-type="fig" rid="F6">F</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Interaction of vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> with AhR protein. <bold>(A,C,E)</bold> The interaction model of the AhR protein with vitamins K<sub>1</sub>, K<sub>2</sub>, or K<sub>3</sub>. <bold>(B,D,F)</bold> Interaction map between residues within the AhR protein with vitamins K<sub>1</sub>, K<sub>2</sub>, or K<sub>3</sub>. <bold>(G)</bold> Quantification of the binding affinity of AhR protein with vitamins K<sub>1</sub>, K<sub>2</sub>, or K<sub>3</sub> using microscale thermophoresis assay.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0006.tif"/>
</fig>
<p>We further used the MST assay to detect AhR protein binding with vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub>. The MST results indicated that the dissociation constant (Kd) values of AhR protein with vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> were 1.99 &#x003BC;M, 586.14 nM, and 2.17 &#x003BC;M, respectively (<xref ref-type="fig" rid="F6">Figure 6G</xref>). These findings showed that vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> were able to bind AhR and are likely to modulate its activity.</p></sec>
<sec>
<title>Effects of Pht analog vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> on the <italic>P. aeruginosa pqs</italic> QS system</title>
<p>We then tested whether Pht analogs, vitamins K1, K2, and K3, had an inhibitory effect on the <italic>P. aeruginosa pqs</italic> QS system. The growth of the reporter strain (OD<sub>600nm</sub>) was monitored to ensure that vitamins K<sub>1</sub>, K<sub>2</sub>, or K<sub>3</sub> would not affect the growth of <italic>P. aeruginosa</italic> strains (<xref ref-type="fig" rid="F7">Figure 7A</xref>). GFP expression was normalized by dividing the GFP values by the OD values measured at respective time points. Vitamin K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> were found to inhibit <italic>pqsA</italic>-<italic>gfp</italic> expression dose-dependently without affecting growth (<xref ref-type="fig" rid="F7">Figures 7B</xref>&#x02013;<xref ref-type="fig" rid="F7">D</xref>). In conclusion, Pht and its analogs, vitamins K1, K2, and K3, inhibited the <italic>P. aeruginosa pqs</italic> QS system. In addition, we performed molecular docking to predict the binding modes of vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> to PqsR protein (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 2</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>Vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> inhibited <italic>P. aeruginosa pqs</italic> QS system. <bold>(A)</bold> Growth curve of ABTGC media (Blank), <italic>P. aeruginosa</italic> WT, WT&#x0002B;2000 nM vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> strains. <bold>(B)</bold> Dose-dependent inhibition curves of vitamins K<sub>1</sub> with QS monitor PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. <bold>(C)</bold> Dose-dependent inhibition curves of vitamins K<sub>2</sub> with QS monitor PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub>. <bold>(D)</bold> Dose-dependent inhibition curves of vitamins K<sub>3</sub> with QS monitor PAO1 P<sub>pqsA&#x02212;<italic>gfp</italic></sub>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0007.tif"/>
</fig></sec></sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>QSI compounds are effective agents for inhibiting <italic>P. aeruginosa</italic> virulence and biofilms, and the mode of action of some QSIs has been extensively investigated <italic>in vivo</italic> (Kalia et al., <xref ref-type="bibr" rid="B26">2019</xref>). For example, the sulfur-containing compound ajoene (4,5,9-trithiadodeca-1,6,11-triene 9-oxide) purified from garlic extract was shown <italic>in vitro</italic> to significantly inhibit a subclass of QS-regulated <italic>P. aeruginosa</italic> genes and rhamnolipid production in a dose-dependent manner. Besides, in a murine pulmonary infection model, a significant clearing of infecting <italic>P. aeruginosa</italic> was detected in ajoene-treated mice compared to a nontreated control group (Jakobsen et al., <xref ref-type="bibr" rid="B22">2012</xref>). Additionally, mBTL is a chemical molecule synthesized to inhibit the two <italic>P. aeruginosa</italic> QS regulators, LasR and RhlR, which were shown to reduce the production of the virulence factor pyocyanin and biofilm formation, protecting <italic>Caenorhabditis elegans</italic> from killing by <italic>P. aeruginosa</italic> (O&#x00027;loughlin et al., <xref ref-type="bibr" rid="B37">2013</xref>). However, most QSIs are discovered from screening chemical compound libraries and may be highly toxic to the human body. Therefore, it is urgent to discover and develop harmless QSI compounds such as microbial metabolites that could be detected in human lung tissues at high concentrations.</p>
<p>Recently, one MTb natural metabolite Pht analog Plumbagin secreted by <italic>Plumbago zeylanica</italic> L. was identified to inhibit <italic>P. aeruginosa</italic> LasR protein-regulated <italic>las</italic> QS system (Qais et al., <xref ref-type="bibr" rid="B42">2021</xref>). In this study, we reported the dual-functional <italic>P. aeruginosa</italic> PQS and MTb Pht interact with host AhR and bacterial PqsR proteins (<xref ref-type="fig" rid="F8">Figure 8</xref>). Pht and its analog, vitamin K, promote AhR to facilitate innate immune defense against bacteria through <italic>CYP1B1</italic> and <italic>AHRR</italic>, while PQS had the opposite effect. Moreover, Pht and its analogs, vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub>, were also effective QSIs that can inhibit <italic>P. aeruginosa pqs</italic> QS system, pyocyanin, and biofilm. Pht has been detected in the bronchoalveolar fluid with a concentration of up to 50 &#x003BC;M in most patients with tuberculosis (Gardner, <xref ref-type="bibr" rid="B14">1996</xref>). The toxicity of Pht was previously tested in mice at a dose of 200 mg/kg oral and 150 mg/kg intraperitoneal, which is believed to be safe for <italic>in vivo</italic> usage (<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/10221">https://pubchem.ncbi.nlm.nih.gov/compound/10221</ext-link>). Besides, Pht analogs and vitamin K also naturally exist in the human body and have been proven to boost the human immune system by preventing calcium deposition, elastic fiber degradation, thrombosis, and inflammation in blood vessels or lungs (Janssen et al., <xref ref-type="bibr" rid="B23">2021</xref>). The vitamin K family has been approved by the FDA and long-term used as human drugs and healthy foods without toxicity. Thus, Pht and Vitamin K could be potentially harmless QSI drugs for controlling <italic>P. aeruginosa</italic> infections and increasing human immune systems.</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>A model illustrates how <italic>P. aeruginosa</italic> PqsR and host protein AhR respond to MTb natural metabolites PQS and Pht. Pht and its analog vitamins K promote AhR to facilitate innate pulmonary defense against bacteria through <italic>CYP1B1</italic> and <italic>AHRR</italic> while repressed PqsR to block bacterial virulence factors such as <italic>pqs</italic> QS system, pyocyanin, and biofilm. Data suggest that PQS has the opposite effect.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-896687-g0008.tif"/>
</fig>
<p>Carbapenems, including imipenem, meropenem, and ertapenem, are common antibiotics to treat <italic>P. aeruginosa</italic> biofilm-associated infections in patients with CF (Yan and Bassler, <xref ref-type="bibr" rid="B49">2019</xref>). However, due to the long-term use of these antibiotics, <italic>P. aeruginosa</italic> evolved multidrug resistance mechanisms to them, such as expression of efflux pumps and overexpression of biofilm structural components (Hall and Mah, <xref ref-type="bibr" rid="B16">2017</xref>). Specifically, QSIs are newly developed specific drugs that interfere with <italic>P. aeruginosa</italic> virulent gene expression without affecting bacterial growth (Carradori et al., <xref ref-type="bibr" rid="B1">2020</xref>). Therefore, using a combination of QSI drugs and antibiotics is a promising strategy for treating chronic biofilm infections caused by <italic>P. aeruginosa</italic>. The treatment of an <italic>in vivo P. aeruginosa</italic> foreign-body biofilm infection with a combination of QSI drugs such as Furanone C30, ajoene, or horseradish juice extract and tobramycin showed a synergistic clearing effect on the bacteria (Christensen et al., <xref ref-type="bibr" rid="B3">2012</xref>). It also has been shown that <italic>in vitro</italic>-grown <italic>P. aeruginosa</italic> biofilms in the absence of an active QS system (either by mutation of crucial QS genes or by using QSI drugs) are more susceptible to tobramycin, indicating that QSI drugs and tobramycin have combinational effects on eradicating bacterial biofilms (H&#x000F8;iby et al., <xref ref-type="bibr" rid="B19">2010</xref>). Besides, QSIs such as patulin, penicillic acid, baicalin hydrate, and cinnamaldehyde are effective in increasing the susceptibility of <italic>P. aeruginosa</italic> to antibiotics (Hentzer and Givskov, <xref ref-type="bibr" rid="B18">2003</xref>). These findings suggest that the synergistic treatment of <italic>P. aeruginosa</italic> infections is an effective strategy to prevent biofilm by first disabling the QS system by reducing bacterial virulence with QSI drugs and then killing the bacteria with antibiotics. However, there is no evidence of Pht synergistic treatment with antibiotics for <italic>P. aeruginosa</italic> infections. Thus, we will further examine the efficiency of Pht and its analogs in combination with antibiotics to treat <italic>P. aeruginosa</italic> infections.</p>
<p>In conclusion, using small molecules targeting the QS systems is a potential strategy for eradicating and preventing <italic>P. aeruginosa</italic> infections. MTb natural metabolite Pht and <italic>P. aeruginosa</italic> PQS are both ligands of human AhR receptors with structural similarity. In this study, Pht was confirmed as an inhibitor of the <italic>pqs</italic> QS system of <italic>P. aeruginosa</italic> with an optimal working concentration of 750 nM and is likely to compete with PQS in binding with PqsR. <italic>Pseudomonas aeruginosa</italic>&#x00027;s key virulence factor, pyocyanin, and biofilm formation could be reduced with Pht treatment. Pht analog vitamins K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub> were also shown to inhibit the <italic>P. aeruginosa pqs</italic> QS system.</p></sec>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found in the ProteomeXchange Consortium with the dataset identifier PXD032384.</p></sec>
<sec id="s6">
<title>Author contributions</title>
<p>TJ, LY, and GL designed the study. TJ, DL, XB, and ML performed experiments. TJ, ZC, JF, ZL, PW, XK, GZ, and AJ analyzed the results. TJ, ZC, and LY drafted and revised the manuscript. All authors contributed to the article and approved the submitted version.</p></sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>This work was supported by the National Key R&#x00026;D Program of China (2021YFA1300902); Guangdong Natural Science Foundation for Distinguished Young Scholar (2020B1515020003); the Shenzhen Key Laboratory of Gene Regulation and Systems Biology, Southern University of Science and Technology (ZDSYS20200811144002008); and Shenzhen Science and Technology Program KQTD20200909113758004.</p></sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
</body>
<back>
<sec sec-type="supplementary-material" id="s9">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.896687/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2022.896687/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.XLSX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carradori</surname> <given-names>S.</given-names></name> <name><surname>Di Giacomo</surname> <given-names>N.</given-names></name> <name><surname>Lobefalo</surname> <given-names>M.</given-names></name> <name><surname>Luisi</surname> <given-names>G.</given-names></name> <name><surname>Campestre</surname> <given-names>C.</given-names></name> <name><surname>Sisto</surname> <given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Biofilm and Quorum Sensing inhibitors: the road so far</article-title>. <source>Expert Opin. Ther. Pat.</source> <volume>30</volume>, <fpage>917</fpage>&#x02013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1080/13543776.2020.1830059</pub-id><pub-id pub-id-type="pmid">32985271</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>K. H.</given-names></name> <name><surname>Schweizer</surname> <given-names>H. P.</given-names></name></person-group> (<year>2005</year>). <article-title>An improved method for rapid generation of unmarked <italic>Pseudomonas aeruginosa</italic> deletion mutants</article-title>. <source>BMC Microbiol.</source> <volume>5</volume>, <fpage>30</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-5-30</pub-id><pub-id pub-id-type="pmid">15907219</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname> <given-names>L. D.</given-names></name> <name><surname>Van Gennip</surname> <given-names>M.</given-names></name> <name><surname>Jakobsen</surname> <given-names>T. H.</given-names></name> <name><surname>Alhede</surname> <given-names>M.</given-names></name> <name><surname>Hougen</surname> <given-names>H. P.</given-names></name> <name><surname>H&#x000F8;iby</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against <italic>Pseudomonas aeruginosa</italic> in an intraperitoneal foreign-body infection mouse model</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>67</volume>, <fpage>1198</fpage>&#x02013;<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dks002</pub-id><pub-id pub-id-type="pmid">23615559</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname> <given-names>J. W.</given-names></name> <name><surname>Montanaro</surname> <given-names>L.</given-names></name> <name><surname>Arciola</surname> <given-names>C. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Biofilm in implant infections: its production and regulation</article-title>. <source>Int. J. Artif. Organs</source> <volume>28</volume>, <fpage>1062</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1177/039139880502801103</pub-id><pub-id pub-id-type="pmid">16353112</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname> <given-names>C. S.</given-names></name> <name><surname>Bolig</surname> <given-names>T.</given-names></name> <name><surname>Torabi-Parizi</surname> <given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Mechanisms and targeted therapies for <italic>Pseudomonas aeruginosa</italic> lung infection</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>197</volume>, <fpage>708</fpage>&#x02013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201705-1043SO</pub-id><pub-id pub-id-type="pmid">29087211</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname> <given-names>P.</given-names></name> <name><surname>Khan</surname> <given-names>A.</given-names></name> <name><surname>Chattopadhyay</surname> <given-names>P.</given-names></name> <name><surname>Mehta</surname> <given-names>P.</given-names></name> <name><surname>Sahni</surname> <given-names>S.</given-names></name> <name><surname>Sharma</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Co-infections as modulators of disease outcome: minor players or major players?</article-title> <source>Front. Microbiol.</source> <volume>12</volume>, <fpage>664386</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.664386</pub-id><pub-id pub-id-type="pmid">34295314</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname> <given-names>G.</given-names></name> <name><surname>Kutuzov</surname> <given-names>M. A.</given-names></name> <name><surname>Ridge</surname> <given-names>K. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The inflammasome in lung diseases</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>303</volume>, <fpage>L627</fpage>&#x02013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00225.2012</pub-id><pub-id pub-id-type="pmid">22904168</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehrt</surname> <given-names>S.</given-names></name> <name><surname>Schnappinger</surname> <given-names>D.</given-names></name> <name><surname>Rhee</surname> <given-names>K. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>16</volume>, <fpage>496</fpage>&#x02013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-018-0013-4</pub-id><pub-id pub-id-type="pmid">29691481</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falkinham</surname> <given-names>J. O.</given-names> <suffix>III</suffix></name> <name><surname>Hilborn</surname> <given-names>E. D.</given-names></name> <name><surname>Arduino</surname> <given-names>M. J.</given-names></name> <name><surname>Pruden</surname> <given-names>A.</given-names></name> <name><surname>Edwards</surname> <given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Epidemiology and ecology of opportunistic premise plumbing pathogens: <italic>Legionella pneumophila, Mycobacterium avium</italic>, and <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Environ. Health Perspect.</source> <volume>123</volume>, <fpage>749</fpage>&#x02013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1408692</pub-id><pub-id pub-id-type="pmid">25793551</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franceschini</surname> <given-names>A.</given-names></name> <name><surname>Szklarczyk</surname> <given-names>D.</given-names></name> <name><surname>Frankild</surname> <given-names>S.</given-names></name> <name><surname>Kuhn</surname> <given-names>M.</given-names></name> <name><surname>Simonovic</surname> <given-names>M.</given-names></name> <name><surname>Roth</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>STRING v9.1: protein-protein interaction networks, with increased coverage and integration</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>D808</fpage>&#x02013;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1094</pub-id><pub-id pub-id-type="pmid">23203871</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fusaro</surname> <given-names>M.</given-names></name> <name><surname>Cianciolo</surname> <given-names>G.</given-names></name> <name><surname>Brandi</surname> <given-names>M. L.</given-names></name> <name><surname>Ferrari</surname> <given-names>S.</given-names></name> <name><surname>Nickolas</surname> <given-names>T. L.</given-names></name> <name><surname>Tripepi</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Vitamin K and osteoporosis</article-title>. <source>Nutrients</source> <volume>12</volume>, <fpage>625</fpage>. <pub-id pub-id-type="doi">10.3390/nu12123625</pub-id><pub-id pub-id-type="pmid">33255760</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname> <given-names>D. R.</given-names></name></person-group> (<year>1991</year>). <article-title><italic>Pseudomonas aeruginosa</italic> elastase and elastolysis revisited: recent developments</article-title>. <source>Mol. Microbiol.</source> <volume>5</volume>, <fpage>2315</fpage>&#x02013;<lpage>2321</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb02076.x</pub-id><pub-id pub-id-type="pmid">1791748</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ED;a-Reyes</surname> <given-names>S.</given-names></name> <name><surname>Sober&#x000F3;n-Ch&#x000E1;vez</surname> <given-names>G.</given-names></name> <name><surname>Cocotl-Yanez</surname> <given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>The third quorum-sensing system of <italic>Pseudomonas aeruginosa: Pseudomonas</italic> quinolone signal and the enigmatic PqsE protein</article-title>. <source>J. Med. Microbiol.</source> <volume>69</volume>, <fpage>25</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.001116</pub-id><pub-id pub-id-type="pmid">31794380</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname> <given-names>P. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Superoxide production by the mycobacterial and pseudomonad quinoid pigments phthiocol and pyocyanine in human lung cells</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>333</volume>, <fpage>267</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1996.0390</pub-id><pub-id pub-id-type="pmid">8806780</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname> <given-names>J. D.</given-names></name> <name><surname>Chen</surname> <given-names>W.</given-names></name> <name><surname>Parnham</surname> <given-names>S.</given-names></name> <name><surname>Beauchesne</surname> <given-names>K.</given-names></name> <name><surname>Moeller</surname> <given-names>P.</given-names></name> <name><surname>Flume</surname> <given-names>P. A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The role of 2,4-dihydroxyquinoline (DHQ) in <italic>Pseudomonas aeruginosa</italic> pathogenicity</article-title>. <source>PeerJ</source> <volume>4</volume>, <fpage>e1495</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.1495</pub-id><pub-id pub-id-type="pmid">26788419</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>C. W.</given-names></name> <name><surname>Mah</surname> <given-names>T. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>41</volume>, <fpage>276</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1093/femsre/fux010</pub-id><pub-id pub-id-type="pmid">28369412</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hellman</surname> <given-names>L. M.</given-names></name> <name><surname>Fried</surname> <given-names>M. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions</article-title>. <source>Nat. Protoc.</source> <volume>2</volume>, <fpage>1849</fpage>&#x02013;<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.249</pub-id><pub-id pub-id-type="pmid">17703195</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hentzer</surname> <given-names>M.</given-names></name> <name><surname>Givskov</surname> <given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections</article-title>. <source>J. Clin. Invest.</source> <volume>112</volume>, <fpage>1300</fpage>&#x02013;<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1172/JCI20074</pub-id><pub-id pub-id-type="pmid">14597754</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000F8;iby</surname> <given-names>N.</given-names></name> <name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name> <name><surname>Givskov</surname> <given-names>M.</given-names></name> <name><surname>Molin</surname> <given-names>S.</given-names></name> <name><surname>Ciofu</surname> <given-names>O.</given-names></name></person-group> (<year>2010</year>). <article-title>Antibiotic resistance of bacterial biofilms</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>35</volume>, <fpage>322</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.12.011</pub-id><pub-id pub-id-type="pmid">20149602</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>C. L.</given-names></name> <name><surname>Anderson</surname> <given-names>M. T.</given-names></name> <name><surname>Mobley</surname> <given-names>H. L. T.</given-names></name> <name><surname>Bachman</surname> <given-names>M. A.</given-names></name></person-group> (<year>2021</year>). <article-title>Pathogenesis of gram-negative bacteremia</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>34</volume>, <fpage>e00234</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00234-20</pub-id><pub-id pub-id-type="pmid">33692149</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Ilangovan</surname> <given-names>A.</given-names></name> <name><surname>Fletcher</surname> <given-names>M.</given-names></name> <name><surname>Rampioni</surname> <given-names>G.</given-names></name> <name><surname>Pustelny</surname> <given-names>C.</given-names></name> <name><surname>Rumbaugh</surname> <given-names>K.</given-names></name> <name><surname>Heeb</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2013</year>). Structural basis for native agonist and synthetic inhibitor recognition by the <italic>Pseudomonas aeruginosa</italic> quorum sensing regulator PqsR (MvfR). <italic>PLoS Pathog</italic>. <volume>9</volume>, <fpage>e1003508</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003508</pub-id><pub-id pub-id-type="pmid">23935486</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname> <given-names>T. H.</given-names></name> <name><surname>Van Gennip</surname> <given-names>M.</given-names></name> <name><surname>Phipps</surname> <given-names>R. K.</given-names></name> <name><surname>Shanmugham</surname> <given-names>M. S.</given-names></name> <name><surname>Christensen</surname> <given-names>L. D.</given-names></name> <name><surname>Alhede</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>2314</fpage>&#x02013;<lpage>2325</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.05919-11</pub-id><pub-id pub-id-type="pmid">22314537</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname> <given-names>R.</given-names></name> <name><surname>Visser</surname> <given-names>M. P. J.</given-names></name> <name><surname>Dofferhoff</surname> <given-names>A. S. M.</given-names></name> <name><surname>Vermeer</surname> <given-names>C.</given-names></name> <name><surname>Janssens</surname> <given-names>W.</given-names></name> <name><surname>Walk</surname> <given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019</article-title>. <source>Br. J. Nutr.</source> <volume>126</volume>, <fpage>191</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114520003979</pub-id><pub-id pub-id-type="pmid">33023681</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>P.</given-names></name> <name><surname>Binns</surname> <given-names>D.</given-names></name> <name><surname>Chang</surname> <given-names>H. Y.</given-names></name> <name><surname>Fraser</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Mcanulla</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>InterProScan 5: genome-scale protein function classification</article-title>. <source>Bioinformatics</source> <volume>30</volume>, <fpage>1236</fpage>&#x02013;<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu031</pub-id><pub-id pub-id-type="pmid">24451626</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname> <given-names>V. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Quorum sensing inhibitors: an overview</article-title>. <source>Biotechnol. Adv.</source> <volume>31</volume>, <fpage>224</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2012.10.004</pub-id><pub-id pub-id-type="pmid">23142623</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname> <given-names>V. C.</given-names></name> <name><surname>Patel</surname> <given-names>S. K. S.</given-names></name> <name><surname>Kang</surname> <given-names>Y. C.</given-names></name> <name><surname>Lee</surname> <given-names>J. K.</given-names></name></person-group> (<year>2019</year>). <article-title>Quorum sensing inhibitors as antipathogens: biotechnological applications</article-title>. <source>Biotechnol. Adv.</source> <volume>37</volume>, <fpage>68</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.006</pub-id><pub-id pub-id-type="pmid">30471318</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. S.</given-names></name> <name><surname>Lee</surname> <given-names>S. H.</given-names></name> <name><surname>Byun</surname> <given-names>Y.</given-names></name> <name><surname>Park</surname> <given-names>H. D.</given-names></name></person-group> (<year>2015</year>). <article-title>6-Gingerol reduces <italic>Pseudomonas aeruginosa</italic> biofilm formation and virulence <italic>via</italic> quorum sensing inhibition</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>8656</fpage>. <pub-id pub-id-type="doi">10.1038/srep08656</pub-id><pub-id pub-id-type="pmid">25728862</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>G. W.</given-names></name> <name><surname>Hassett</surname> <given-names>D. J.</given-names></name> <name><surname>Ran</surname> <given-names>H.</given-names></name> <name><surname>Kong</surname> <given-names>F.</given-names></name></person-group> (<year>2004a</year>). <article-title>The role of pyocyanin in Pseudomonas aeruginosa infection</article-title>. <source>Trends Mol. Med.</source> <volume>10</volume>, <fpage>599</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2004.10.002</pub-id><pub-id pub-id-type="pmid">15567330</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>G. W.</given-names></name> <name><surname>Ran</surname> <given-names>H.</given-names></name> <name><surname>Kong</surname> <given-names>F.</given-names></name> <name><surname>Hassett</surname> <given-names>D. J.</given-names></name> <name><surname>Mavrodi</surname> <given-names>D.</given-names></name></person-group> (<year>2004b</year>). <article-title><italic>Pseudomonas aeruginosa</italic> pyocyanin is critical for lung infection in mice</article-title>. <source>Infect. Immun.</source> <volume>72</volume>, <fpage>4275</fpage>&#x02013;<lpage>4278</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.7.4275-4278.2004</pub-id><pub-id pub-id-type="pmid">15213173</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leclerc</surname> <given-names>D.</given-names></name> <name><surname>Staats Pires</surname> <given-names>A. C.</given-names></name> <name><surname>Guillemin</surname> <given-names>G. J.</given-names></name> <name><surname>Gilot</surname> <given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies</article-title>. <source>Curr. Opin. Immunol.</source> <volume>70</volume>, <fpage>15</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2020.12.003</pub-id><pub-id pub-id-type="pmid">33429228</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lichstein</surname> <given-names>H. C.</given-names></name> <name><surname>Van De Sand</surname> <given-names>V. F.</given-names></name></person-group> (<year>1946</year>). <article-title>The antibiotic activity of violacein, prodigiosin, and phthiocol</article-title>. <source>J. Bacteriol.</source> <volume>52</volume>, <fpage>145</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1128/jb.52.1.145-146.1946</pub-id><pub-id pub-id-type="pmid">16561146</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majik</surname> <given-names>M. S.</given-names></name> <name><surname>Parvatkar</surname> <given-names>P. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Next generation biofilm inhibitors for <italic>Pseudomonas aeruginosa</italic>: Synthesis and rational design approaches</article-title>. <source>Curr. Top. Med. Chem.</source> <volume>14</volume>, <fpage>81</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.2174/1568026613666131113152257</pub-id><pub-id pub-id-type="pmid">24236724</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martiniano</surname> <given-names>S. L.</given-names></name> <name><surname>Sontag</surname> <given-names>M. K.</given-names></name> <name><surname>Daley</surname> <given-names>C. L.</given-names></name> <name><surname>Nick</surname> <given-names>J. A.</given-names></name> <name><surname>Sagel</surname> <given-names>S. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis</article-title>. <source>Ann. Am. Thorac. Soc.</source> <volume>11</volume>, <fpage>36</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1513/AnnalsATS.201309-310OC</pub-id><pub-id pub-id-type="pmid">24251858</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moura-Alves</surname> <given-names>P.</given-names></name> <name><surname>Fa&#x000E9;</surname> <given-names>K.</given-names></name> <name><surname>Houthuys</surname> <given-names>E.</given-names></name> <name><surname>Dorhoi</surname> <given-names>A.</given-names></name> <name><surname>Kreuchwig</surname> <given-names>A.</given-names></name> <name><surname>Furkert</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>AhR sensing of bacterial pigments regulates antibacterial defence</article-title>. <source>Nature</source> <volume>512</volume>, <fpage>387</fpage>&#x02013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1038/nature13684</pub-id><pub-id pub-id-type="pmid">25119038</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Moura-Alves</surname> <given-names>P.</given-names></name> <name><surname>Puyskens</surname> <given-names>A.</given-names></name> <name><surname>Stinn</surname> <given-names>A.</given-names></name> <name><surname>Klemm</surname> <given-names>M.</given-names></name> <name><surname>Guhlich-Bornhof</surname> <given-names>U.</given-names></name> <name><surname>Dorhoi</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Host monitoring of quorum sensing during <italic>Pseudomonas aeruginosa</italic> infection</article-title>. <source>Science</source> 366, aaw1629. <pub-id pub-id-type="doi">10.1126/science.aaw1629</pub-id><pub-id pub-id-type="pmid">31857448</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;boyle</surname> <given-names>N. M.</given-names></name> <name><surname>Banck</surname> <given-names>M.</given-names></name> <name><surname>James</surname> <given-names>C. A.</given-names></name> <name><surname>Morley</surname> <given-names>C.</given-names></name> <name><surname>Vandermeersch</surname> <given-names>T.</given-names></name> <name><surname>Hutchison</surname> <given-names>G. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Open babel: an open chemical toolbox</article-title>. <source>J. Cheminform.</source> <volume>3</volume>, <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id><pub-id pub-id-type="pmid">21982300</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;loughlin</surname> <given-names>C. T.</given-names></name> <name><surname>Miller</surname> <given-names>L. C.</given-names></name> <name><surname>Siryaporn</surname> <given-names>A.</given-names></name> <name><surname>Drescher</surname> <given-names>K.</given-names></name> <name><surname>Semmelhack</surname> <given-names>M. F.</given-names></name> <name><surname>Bassler</surname> <given-names>B. L.</given-names></name></person-group> (<year>2013</year>). <article-title>A quorum-sensing inhibitor blocks <italic>Pseudomonas aeruginosa</italic> virulence and biofilm formation</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume>, <fpage>17981</fpage>&#x02013;<lpage>17986</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1316981110</pub-id><pub-id pub-id-type="pmid">24143808</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname> <given-names>A.</given-names></name> <name><surname>Tuccinardi</surname> <given-names>D.</given-names></name> <name><surname>D&#x00027;onofrio</surname> <given-names>L.</given-names></name> <name><surname>Watanabe</surname> <given-names>M.</given-names></name> <name><surname>Maggi</surname> <given-names>D.</given-names></name> <name><surname>Maurizi</surname> <given-names>A. R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Vitamin K and osteoporosis: myth or reality?</article-title> <source>Metabolism</source> <volume>70</volume>, <fpage>57</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2017.01.032</pub-id><pub-id pub-id-type="pmid">28403946</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname> <given-names>J. P.</given-names></name> <name><surname>Pesci</surname> <given-names>E. C.</given-names></name> <name><surname>Iglewski</surname> <given-names>B. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Roles of <italic>Pseudomonas aeruginosa</italic> las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes</article-title>. <source>J. Bacteriol.</source> <volume>179</volume>, <fpage>5756</fpage>&#x02013;<lpage>5767</lpage>. <pub-id pub-id-type="doi">10.1128/jb.179.18.5756-5767.1997</pub-id><pub-id pub-id-type="pmid">9294432</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pesci</surname> <given-names>E. C.</given-names></name> <name><surname>Milbank</surname> <given-names>J. B.</given-names></name> <name><surname>Pearson</surname> <given-names>J. P.</given-names></name> <name><surname>Mcknight</surname> <given-names>S.</given-names></name> <name><surname>Kende</surname> <given-names>A. S.</given-names></name> <name><surname>Greenberg</surname> <given-names>E. P.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Quinolone signaling in the cell-to-cell communication system of <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>96</volume>, <fpage>11229</fpage>&#x02013;<lpage>11234</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.20.11229</pub-id><pub-id pub-id-type="pmid">10500159</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname> <given-names>E. F.</given-names></name> <name><surname>Goddard</surname> <given-names>T. D.</given-names></name> <name><surname>Huang</surname> <given-names>C. C.</given-names></name> <name><surname>Couch</surname> <given-names>G. S.</given-names></name> <name><surname>Greenblatt</surname> <given-names>D. M.</given-names></name> <name><surname>Meng</surname> <given-names>E. C.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>UCSF Chimera&#x02013;a visualization system for exploratory research and analysis</article-title>. <source>J. Comput. Chem.</source> <volume>25</volume>, <fpage>1605</fpage>&#x02013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qais</surname> <given-names>F. A.</given-names></name> <name><surname>Khan</surname> <given-names>M. S.</given-names></name> <name><surname>Ahmad</surname> <given-names>I.</given-names></name> <name><surname>Husain</surname> <given-names>F. M.</given-names></name> <name><surname>Al-Kheraif</surname> <given-names>A. A.</given-names></name> <name><surname>Arshad</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Plumbagin inhibits quorum sensing-regulated virulence and biofilms of Gram-negative bacteria: <italic>in vitro</italic> and <italic>in silico</italic> investigations</article-title>. <source>Biofouling</source> <volume>37</volume>, <fpage>724</fpage>&#x02013;<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2021.1955250</pub-id><pub-id pub-id-type="pmid">34396840</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seeliger</surname> <given-names>D.</given-names></name> <name><surname>De Groot</surname> <given-names>B. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Ligand docking and binding site analysis with PyMOL and Autodock/Vina</article-title>. <source>J. Comput. Aided Mol. Des.</source> <volume>24</volume>, <fpage>417</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-010-9352-6</pub-id><pub-id pub-id-type="pmid">20401516</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinde</surname> <given-names>V.</given-names></name> <name><surname>Wadekar</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Spectral and antibacterial investigations of Er(III) Juglonates</article-title>. <source>Inter. J. ChemTech. Res.</source> <volume>10</volume>, <fpage>740</fpage>&#x02013;<lpage>748</lpage>.</citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sober&#x000F3;n-Ch&#x000E1;vez</surname> <given-names>G.</given-names></name> <name><surname>L&#x000E9;pine</surname> <given-names>F.</given-names></name> <name><surname>D&#x000E9;ziel</surname> <given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Production of rhamnolipids by <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>68</volume>, <fpage>718</fpage>&#x02013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-005-0150-3</pub-id><pub-id pub-id-type="pmid">16160828</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname> <given-names>V.</given-names></name> <name><surname>Tajani</surname> <given-names>A. S.</given-names></name> <name><surname>Ghodsi</surname> <given-names>R.</given-names></name> <name><surname>Bazzaz</surname> <given-names>B. S. F.</given-names></name></person-group> (<year>2019</year>). <article-title>Anti-PqsR compounds as next-generation antibacterial agents against <italic>Pseudomonas aeruginosa</italic>: a review</article-title>. <source>Eur. J. Med. Chem.</source> <volume>172</volume>, <fpage>26</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.03.049</pub-id><pub-id pub-id-type="pmid">30939351</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasarao</surname> <given-names>S.</given-names></name> <name><surname>Nizalapur</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>T. T.</given-names></name> <name><surname>Wenholz</surname> <given-names>D. S.</given-names></name> <name><surname>Trivedi</surname> <given-names>P.</given-names></name> <name><surname>Ghosh</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Design, synthesis and biological evaluation of triazole-containing 2-phenylindole and salicylic acid as quorum sensing inhibitors against <italic>Pseudomonas aeruginosa</italic></article-title>. <source>ChemistSelect</source> <volume>3</volume>, <fpage>9170</fpage>&#x02013;<lpage>9180</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201801622</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname> <given-names>A. C.</given-names></name> <name><surname>Laskowski</surname> <given-names>R. A.</given-names></name> <name><surname>Thornton</surname> <given-names>J. M.</given-names></name></person-group> (<year>1995</year>). <article-title>LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions</article-title>. <source>Protein Eng.</source> <volume>8</volume>, <fpage>127</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1093/protein/8.2.127</pub-id><pub-id pub-id-type="pmid">7630882</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>J.</given-names></name> <name><surname>Bassler</surname> <given-names>B. L.</given-names></name></person-group> (<year>2019</year>). <article-title>Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms</article-title>. <source>Cell Host Microbe.</source> <volume>26</volume>, <fpage>15</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2019.06.002</pub-id><pub-id pub-id-type="pmid">31295420</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Barken</surname> <given-names>K. B.</given-names></name> <name><surname>Skindersoe</surname> <given-names>M. E.</given-names></name> <name><surname>Christensen</surname> <given-names>A. B.</given-names></name> <name><surname>Givskov</surname> <given-names>M.</given-names></name> <name><surname>Tolker-Nielsen</surname> <given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of iron on DNA release and biofilm development by <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Microbiology</source> <volume>153</volume>, <fpage>1318</fpage>&#x02013;<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.2006/004911-0</pub-id><pub-id pub-id-type="pmid">17464046</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Zhou</surname> <given-names>F.</given-names></name> <name><surname>Kong</surname> <given-names>L.</given-names></name> <name><surname>Qiu</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>TMT based proteomic analysis of human follicular fluid from overweight/obese and normal-weight patients with polycystic ovary syndrome</article-title>. <source>Front. Endocrinol.</source> <volume>10</volume>, <fpage>821</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2019.00821</pub-id><pub-id pub-id-type="pmid">31983920</pub-id></citation></ref>
</ref-list> 
</back>
</article> 